Health

J&J attracts Chinese interest for diabetes business in potential $3B to $4B deal: Sources

Chinese bidders are circling a diabetes care business owned by the globe’s largest health-care company Johnson & Johnson in a deal that will could fetch up to $4 billion, 5 people with direct knowledge told Reuters. completely new Brunswick, N.J.-based J&J said in January last year the item was evaluating options for its diabetes care companies, specifically LifeScan, Animas, as ...

Read More »

6 amazing medical advancements to expect in 2018

Things move fast from the entire world of modern medicine, nevertheless if expert predictions about what to expect in 2018 prove true, they might move at a quicker speed than anyone anticipated. the idea could also see technology companies start to become as important a player from the health-care world as pharmaceutical companies. Breakthroughs in everything via patient monitoring to ...

Read More »

HIPAA not reason for difficult medical record sharing

The tech industry’s viewpoint was summarized over the weekend by Silicon Valley venture capitalist Bill Gurley, who pointed out on Twitter in which the “MRI industry,” meaning medical imaging, still lives on “sneaker net in addition to also faxes.” He was surprised in which the files couldn’t be shared online, as they are “not even in which large.” Gurley went ...

Read More »

Walmart offers free opioid disposal product

Walmart will offer a drug disposal product — for free — to pharmacy customers as part of an effort to combat the nation’s opioid abuse epidemic, the retail giant said Wednesday. The product, a powder known as DisposeRX, when mixed with warm water as well as prescription medication in a pill bottle creates a solid in which can then be ...

Read More »

Celgene can be in talks to buy Juno Therapeutics

Celgene can be in talks to buy biotechnology company Juno Therapeutics, The Wall Street Journal reported. The news comes less than a week after the biotech giant announced the idea could buy Impact Biomedicines for $7 billion. Both Impact as well as Juno offer drugs that will could boost Celgene inside the market for blood-cancer treatment. Celgene has been fighting ...

Read More »

Buybacks should calm fears of a major market decline

The worst intra-day market reversal in nearly a year might’ve spooked investors, however CNBC’s Jim Cramer argued which the market still incorporates a major driver in its metaphorical back pocket. “I’m talking about the ongoing stock shortage,” the “Mad Money” host said. “The shortage is usually so real, so palpable, which I think This particular could become a major theme ...

Read More »

Merck shares jump after combination trial shows Keytruda extends lung cancer survival

A cocktail of Merck’s blockbuster drug Keytruda in addition to two chemotherapy medicines helped lung cancer patients live longer in addition to stopped the disease via advancing, early results via a key study showed on Tuesday. Merck’s shares rose 7 percent to $62.77 after data via the late-stage study. The results cement Merck’s position as a front-runner from the race ...

Read More »

Amazon hiring HIPAA expert

Amazon can be looking to hire an expert in a set of health privacy regulations known as HIPAA, according to a brand new job listing. The company can be looking for a professional who can “own in addition to operate” the security in addition to compliance aspects of a brand new initiative. The person will also ensure in which the ...

Read More »